IRTC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About iRhythm Technologies Inc

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
CEO
Kevin King
Employees
1157
Headquarters

650 Townsend St Ste 500
San Francisco, California 94103-6227
Phone: 14156325700
www.irhythmtech.com

News

iRhythm: Revenue Upside Less Visible After Q3 Challenges (NASDAQ:IRTC)
Nov 18, 2022 04:50am

iRhythm Technologies'' Q3 results reaffirm our hold thesis. Revenue growth is less certain looking ahead with less visibility on received device rates.


Source:Seeking Alpha
Should You Consider iRhythm Technologies (IRTC) Shares for Investment?
Nov 14, 2022 15:43pm

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, its Investor Class fund ARTSX returned 3.23%, Advisor Class fund APDSX posted a return of 3.27%, and Institutional Class fund APHSX returned 3.27%, compared to a […]


Source:Insider Monkey
How should investors view iRhythm Technologies Inc. (IRTC)?
Nov 10, 2022 16:08pm

As of Wednesday, iRhythm Technologies Inc.’s (NASDAQ:IRTC) stock closed at $96.11, down from $96.80 the previous day. While iRhythm Technologies Inc. has underperformed by -0.71%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, IRTC fell by -6.79%, with highs and lows ranging from $169.54 to $86.73, […]


Source:US Post News
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective
Nov 06, 2022 17:30pm

A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective SAN FRANCISCO, Nov. 06, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and


Source:Wallstreet:Online
Is Now An Ideal Time To Purchase iRhythm Technologies Inc. (NASDAQ: IRTC) Stock?
Nov 02, 2022 18:00pm

iRhythm Technologies Inc. (NASDAQ:IRTC) traded at $118.44 at last check on Wednesday, November 02, made a downward move of -6.57% on its previous day’s price. Looking at the stock we see that its previous close was $126.77 and the beta (5Y monthly) reads 1.33 with the day’s price range being $126.74 – $131.51. In terms … Is Now An Ideal Time To Purchase iRhythm Technologies Inc. (NASDAQ: IRTC) Stock? Read More »


Source:Stocks Register
You Should Read This Analysis Before Investing in iRhythm Technologies Inc. (NASDAQ:IRTC)
Nov 02, 2022 17:32pm

iRhythm Technologies Inc. (IRTC)’s stock has witnessed a price declined of -5.96% from the previous close with its current price standing at $119.21. Its current price is -29.69% under its 52-week high of $169.54 and 65.57% more than its 52-week low of $72.00. Based on the past 30-day period, the stock price is -12.99% below […]


Source:US Post News
iRhythm Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
Nov 02, 2022 12:30pm

SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today commented on the recent announcement from the Centers for Medicare and Medicaid Services (“CMS”) that it has issued the Medicare Physician Fee Schedule (MPFS) Final Rule for Calendar


Source:Wallstreet:Online
iRhythm Posts Smaller Than Expected Loss In Q3, But Shares Fall On Lowered Annual Guidance
Nov 02, 2022 10:28am

iRhythm Technologies Inc (NASDAQ: IRTC ) posted an adjusted EPS loss of $(0.63) , better than $(0.81) a year ago and the consensus of $(0.83). The wearable heart monitor developer recorded sales growth of 21.6% to $103.87 million. "Despite the ongoing staffing and capacity challenges, we grew registration volumes by more than 20% in the third … Full story available on Benzinga.com


Source:Benzinga
iRhythm Technologies, Inc. (IRTC) Q3 2022 Earnings Call Transcript
Nov 02, 2022 03:07am

iRhythm Technologies, Inc. (NASDAQ:NASDAQ:IRTC) Q3 2022 Earnings Conference Call November 01, 2022 04:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations…


Source:Seeking Alpha
iRhythm Technologies GAAP EPS of -$0.71 beats by $0.12, revenue of $103.9M misses by $2.23M
Nov 01, 2022 20:21pm

iRhythm Technologies press release (IRTC): Q3 GAAP EPS of -$0.71 beats by $0.12.Revenue of $103.9M (+21.7% Y/Y) misses by $2.23M.Gross margin of 68.3%, a 2.6 percentage…


Source:Seeking Alpha
iRhythm Technologies Announces Third Quarter 2022 Financial Results
Nov 01, 2022 20:05pm

SAN FRANCISCO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today reported financial results for the three months ended September 30, 2022.


Source:GlobeNewswire
iRhythm Technologies''s Earnings Outlook
Oct 31, 2022 17:41pm

iRhythm Technologies (NASDAQ: IRTC ) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here''s what investors need to know before the announcement. Analysts estimate that iRhythm Technologies will report an earnings per share (EPS) of $-0.83. iRhythm Technologies bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com


Source:Benzinga
iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022
Oct 20, 2022 20:05pm

SAN FRANCISCO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2022 after the close of trading on Tuesday, November 1, 2022. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.


Source:GlobeNewswire
7 Robotic Stocks to Buy for the Coming Robot Boom
Oct 12, 2022 12:38pm

The robotics industry has been growing at an incredible pace, and the computing power needed for these mechatronic devices is getting cheaper by the day. The increased computing power and data handling capabilities of mechatronic devices are allowing them new actions that previously weren’t possible for humans. Robotics is disrupting several industries healthcare, logistics, and automotive, creating opportunities like never before. Hence, robotics stocks have before more pertinent for investors than ever before. A report suggests that The global robotics market is expected to grow at an annualized rate of 22.8% over the next ten years. It will reach $214 billion in 2030 as demand increases for industrial robots and companies improve their technology. The changing preferences of consumers are leading to innovation in the robotics industry. For example, artificial intelligence has significantly improved human-robot interactions with chip advances that allow them to work more efficiently together.


Source:InvestorPlace